Oxidative stress, cell damage and its possible prevention by alpha-tocopherol: Cardiovascular and other cells

Alcohol and Heart Disease

Volumn , Issue , 2002, Pages 120-140

  Preedy, Victor R ^a   Seitz, Helmut ^b,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Center of Alcohol Research   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056536770     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (228)

1. Quintanilha AT, Packer L, Davies JM, Racanelli TL, Davies KJ. Membrane effects of vitamin E deficiency: bioenergetic and surface charge density studies of skeletal muscle and liver mitochondria. Ann. N.Y. Acad. Sci. 1982; 393: 32-47.
2. Amiel J, Maziere JC, Beucler I, Koenig M, Reutenauer L, Loux N, Bonnefont D, Feo C, Landrieu P. Familial isolated vitamin E deficiency. Extensive study of a large family with a 5-year therapeutic follow-up. J. Inherit. Metab. Dis. 1995; 18: 333-340.
3. Ouahchi K, Arita M, Kayden H, Hentati F, Ben Hamida M, Sokol R, Arai H, Inoue K, Mandel JL, Koenig M. Ataxia with isolated vitamin E deficiency is caused by mutations in the alphatocopherol transfer protein. Nat. Genet. 1995; 9: 141-145.
4. Hentati A, Deng HX, Hung WY, Nayer M, Ahmed MS, He X, Tim R, Stumpf DA, Siddique T, Ahmed. Human alpha-tocopherol transfer protein: gene structure and mutations in familial vitamin E deficiency. Ann. Neurol. 1996; 39: 295-300.
5. Tanyel MC, Mancano LD. Neurologic findings in vitamin E deficiency. Am. Fam. Physician. 1997; 55: 197-201.
6. Hammans SR, Kennedy CR. Ataxia with isolated vitamin E deficiency presenting as mutation negative Friedreich’s ataxia. J. Neurol. Neurosurg. Psychiatry 1998; 64: 368-370.
7. Chang JY, Liu LZ. Neurotoxicity of cholesterol oxides on cultured cerebellar granule cells. Neurochem. Int. 1998; 32: 317-323.
8. Bolton Smith C, Smith WC, Woodward M, Tunstall Pedoe H. Nutrient intakes of different social-class groups: results from the Scottish Heart Health Study (SHHS). Br. J. Nutr. 1991; 65: 321-335.
9. Bolton Smith C, Woodward M. Antioxidant vitamin adequacy in relation to consumption of sugars. Eur. J. Clin. Nutr. 1995; 49: 124-133.
10. Sinha R, Patterson BH, Mangels AR, Levander OA, Gibson T, Taylor PR, Block G. Determinants of plasma vitamin E in healthy males. Cancer Epidemiol. Biomarkers Prev. 1993; 2: 473-479.
11. Dallongeville J, Marecaux N, Fruchart JC, Amouyel P. Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis. J. Nutr. 1998; 128: 1450-1457.
12. Ellis NI, Lloyd B, Lloyd RS, Clayton BE. Selenium and vitamin E in relation to risk factors for coronary heart disease. J. Clin. Pathol. 1984; 37: 200-206.
13. Houston DK, Johnson MA, Daniel TD, Poon LW. Health and dietary characteristics of supplement users in an elderly population. Int. J. Vitam. Nutr. Res. 1997; 67: 183-191.
14. Lang JK, Gohil K, Packer L, Burk RF. Selenium deficiency, endurance exercise capacity, and antioxidant status in rats. J. Appl. Physiol. 1987; 63: 2532-2535.
15. Chow CK, Ibrahim W, Wei Z, Chan AC. Vitamin E regulates mitochondrial hydrogen peroxide generation. Free Radic. Biol. Med. 1999; 27: 580-587.
16. Wiseman H, Kaur H, Halliwell B. DNA damage and cancer: measurement and mechanism. Cancer Lett. 1995; 93: 113-120.
17. Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, alphatocopherol, and ascorbate. Arch. Biochem. Biophys. 1993; 300: 535-543.
18. Chan KM, Decker EA. Endogenous skeletal muscle antioxidants. Crit. Rev. Food Sci. Nutr. 1994; 34: 403-426.
19. Warren JA, Jenkins RR, Packer L, Witt EH, Armstrong RB. Elevated muscle vitamin E does not attenuate eccentric exercise-induced muscle injury. J. Appl. Physiol. 1992; 72: 2168-2175.
20. Ingelman Sundberg M, Johansson I. Mechanisms of hydroxyl radical formation and ethanol oxidation by ethanol-inducible and other forms of rabbit liver microsomal cytochromes P-450. J. Biol. Chem. 1984; 259: 6447-6458.
21. Ekstrom G, Ingelman Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450 IIE1). Biochem. Pharmacol. 1989; 38: 1313-1319.
22. Cederbaum AI. Oxygen radical generation by microsomes: role of iron and implications for alcohol metabolism and toxicity. Free Radic. Biol. Med. 1989; 7: 559-567.
23. Ekström G, Von Bahr C, Ingelman Sundberg M. Human liver microsomal cytochrome P4502E1. Immunological evaluation of its contribution to microsomal ethanol oxidation, carbon tetrachloride reduction and NAPDH oxidase activity. Biochem. Pharmacol. 1989; 38: 689.
24. Reinke LA, Lai EK, DuBose CM, McCay PB. Reactive free radical generation in vivo in heart and liver of ethanol-fed rats: correlation with radical formation in vitro. Proc. Natl. Acad. Sci. USA 1987; 84: 9223-9227.
25. Albano E, Tomasi A, Goria Gatti L, Dianzani MU. Spin trapping of free radical species produced during the microsomal metabolism of ethanol. Chem. Biol. Interact. 1988; 65: 223-234.
26. Albano E, Tomasi A, Persson JO, Terelius Y, Goria Gatti L, Ingelman Sundberg M, Dianzani MU. Role of ethanol-inducible cytochrome P450 (P450 IIE1) in catalysing the free radical activation of aliphatic alcohols. Biochem. Pharmacol. 1991; 41: 1895-1902.
27. Kukielka E, Dicker E, Cederbaum AI. Increased production of reactive oxygen species by rat liver mitochondria after chronic ethanol treatment. Arch. Biochem. Biophys. 1994; 309: 377-386.
28. Rouach H, Clément M, Orfanelli MT, Janvier B, Nordmann R. Hepatic lipid peroxidation and mitochrondrial susceptibility to peroxidative attacks during ethanol inhalation and withdrawal. Biochim. Biophys. Acta 1983; 753: 439.
29. Sultatos LG. Effects of acute ethanol administration on the hepatic xanthine dehydrogenase/oxidase system in the rat. J. Pharmacol. Exp. Ther. 1988; 246: 946-949.
30. Abbondanza A, Battelli MG, Soffritti M, Cessi C. Xanthine oxidase status in ethanol-intoxicated rat liver. Alcohol Clin. Exp. Res. 1989; 13: 841-844.
31. Kato S, Kawase T, Alderman J, Inatomi N, Lieber CS. Role of xanthine oxidase in ethanolinduced lipid peroxidation in rats. Gastroenterology 1990; 98: 203-210.
32. Puntarulo S, Cederbaum AI. Chemiluminescence from acetaldehyde oxidation by xanthine oxidase involves generation of and interactions with hydroxyl radicals. Alcohol Clin. Exp. Res. 1989; 13: 84-90.
33. Rajagopalan KV, Handler P. Hepatic aldehyde oxidase. III. The substrate binding site. J. Biol. Chem. 1964; 239: 2027.
34. Albano E, Clot P, Comoglio A, Dianzani MU, Tomasi A. Free radical activation of acetaldehyde and its role in protein alkylation. FEBS Lett. 1994; 348: 65-69.
35. Nordback IH, MacGowan S, Potter JJ, Cameron JL. The role of acetaldehyde in the pathogenesis of acute alcoholic pancreatitis. Ann. Surg. 1991; 214: 671-678.
36. Bautista AP, Spitzer JJ. Acute ethanol intoxication stimulates superoxide anion production by in situ perfused rat liver. Hepatology 1992; 15: 892-898.
37. Bautista AP, Spitzer JJ. Postbinge effects of acute alcohol intoxication on hepatic free radical formation. Alcohol Clin. Exp. Res. 1996; 20: 502-509.
38. Roll FJ, Alexander M, Perez HD. Generation of chemotactic activity for neutrophils by liver cells metabolizing ethanol. Free Radic. Biol. Med. 1989; 7: 549-555.
39. Hultcrantz R, Bissell DM, Roll FJ. Iron mediates production of a neutrophil chemoattractant by rat hepatocytes metabolizing ethanol. J. Clin. Invest. 1991; 87: 45-49.
40. Roll FJ, Alexander MA, Cua D, Swanson W, Perez HD. Metabolism of ethanol by rat hepatocytes results in generation of a lipid chemotactic factor: studies using a cell-free system and role of oxygenderived free radicals. Arch. Biochem. Biophys. 1991; 287: 218-224.
41. Tsukamoto H, Kamimura S, Yeager S, Chen HY, Highman TJ, Luo ZZ, Kim CM, Brittenham GM. Hepatic cirrhosis in rats fed a diet with added alcohol and iron. Hepatology 1992; 16: 113A.
42. Shiratori Y, Takada H, Hai K, Kiriyama H, Nagura T, Tanaka M, Matsumoto K, Kamii K. Generation of chemotactic factor by hepatocytes isolated from chronically ethanol-fed rats. Dig. Dis. Sci. 1992; 37: 650-658.
43. Shirley MA, Reidhead CT, Murphy RC. Chemotactic LTB4 metabolites produced by hepatocytes in the presence of ethanol. Biochem. Biophys. Res. Commun. 1992; 185: 604-610.
44. Arteel GE, Kadiiska MB, Rusyn I, Bradford BU, Mason RP, Raleigh JA, Thurman RG. Oxidative stress occurs in perfused rat liver at low oxygen tension by mechanisms involving peroxynitrite. Mol. Pharmacol. 1999; 55: 708-715.
45. Niemela O. Aldehyde-protein adducts in the liver as a result of ethanol-induced oxidative stress. Front. Biosci. 1999; 4: D506-D513.
46. Rapozzi V, Comelli M, Mavelli I, Sentjurc M, Schara M, Perissin L, Giraldi T. Melatonin and oxidative damage in mice liver induced by the prooxidant antitumor drug, adriamycin. In Vivo 1999; 13: 45-50.
47. Aruoma OI. Nutrition and health aspects of free radicals and antioxidants. Food Chem. Toxicol. 1994; 32: 671-683.
48. van der Veen RC, Hinton DR, Incardonna F, Hofman FM. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J. Neuroimmunol. 1997; 77: 1-7.
49. Venters HD Jr, Bonilla LE, Jensen T, Garner HP, Bordayo EZ, Najarian MM, Ala TA, Mason RP, Frey WH, 2nd. Heme from Alzheimer’s brain inhibits muscarinic receptor binding via thiyl radical generation. Brain Res. Mol. Brain Res. 1997; 764: 93-100.
50. Tan S, Zhou F, Nielsen VG, Wang Z, Gladson CL, Parks DA. Sustained hypoxia-ischemia results in reactive nitrogen and oxygen species production and injury in the premature fetal rabbit brain. J. Neuropathol. Exp. Neurol. 1998; 57: 544-553.
51. Hallberg CK, Trocme SD, Ansari NH. Acceleration of corneal wound healing in diabetic rats by the antioxidant trolox. Res. Commun. Mol. Pathol. Pharmacol. 1996; 93: 3-12.
52. Longoni B, Pryor WA, Marchiafava P. Inhibition of lipid peroxidation by N-acetylserotonin and its role in retinal physiology. Biochem. Biophys. Res. Commun. 1997; 233: 778-780.
53. Sohn J, Yoon YH. Iron-induced cytotoxicity in cultured rat retinal neurons. Korean J. Ophthalmol. 1998; 12: 77-84.
54. Netto M, Do Carmo RJ, Martins-Ferreira H. Retinal spreading depression induced by photoactivation:involvement of free radicals and potassium. Brain Res. Mol. Brain Res. 1999; 827: 221-224.
55. Chamulitrat W, Skrepnik NV, Spitzer JJ. Endotoxin-induced oxidative stress in the rat small intestine: role of nitric oxide. Shock 1996; 5: 217-222.
56. Preedy VR. Alcohol and the gastrointestinal tract. Alcohol Clin. Exp. Res. 1996; 20: 48A-50A.
57. Sokol RJ, Hoffenberg EJ. Antioxidants in pediatric gastrointestinal disease. Pediatr. Clin. North Am. 1996; 43: 471-488.
58. +-ATPase to hypertrophy and its marker genes in cardiac myocytes. J. Biol. Chem. 1999; 274: 19323-19328.
59. Benito B, Wahl D, Steudel N, Cordier A, Steiner S. Effects of cyclosporine A on the rat liver and kidney protein pattern, and the influence of vitamin E and C coadministration. Electrophoresis 1995; 16: 1273-1283.
60. Kavutcu M, Canbolat O, Ozturk S, Olcay E, Ulutepe S, Ekinci C, Gokhun IH, Durak I. Reduced enzymatic antioxidant defense mechanism in kidney tissues from gentamicin-treated guinea pigs:effects of vitamins E and C. Nephron 1996; 72: 269-274.
61. Wallis G, Brackett D, Lerner M, Kotake Y, Bolli R, McCay PB. In vivo spin trapping of nitric oxide generated in the small intestine, liver, and kidney during the development of endotoxemia:a time-course study. Shock 1996; 6: 274-278.
62. Schweich MD, Lison D, Lauwerys R. The role of vitamin E in the susceptibility of rat lung and liver microsomes to iron-stimulated peroxidation. Environ. Res. 1995; 70: 62-69.
63. Varsila E, Pesonen E, Andersson S. Early protein oxidation in the neonatal lung is related to development of chronic lung disease. Acta Paediatr. 1995; 84: 1296-1299.
64. Chung FL, Kelloff G, Steele V, Pittman B, Zang E, Jiao D, Rigotty J, Choi CI, Rivenson A. Chemopreventive efficacy of arylalkyl isothiocyanates and N-acetylcysteine for lung tumorigenesis in Fischer rats. Cancer Res. 1996; 56: 772-778.
65. Lenz AG, Costabel U, Maier KL. Oxidized BAL fluid proteins in patients with interstitial lung diseases. Eur. Respir. J. 1996; 9: 307-312.
66. Rosenblum ER, Gavaler JS, Van Thiel DH. Lipid peroxidation: a mechanism for alcohol-induced testicular injury. Free Radic. Biol. Med. 1989; 7: 569-577.
67. Taylor DE, Piantadosi CA. Oxidative metabolism in sepsis and sepsis syndrome. J. Crit. Care 1995; 10: 122-135.
68. Benzie IF. Lipid peroxidation: a review of causes, consequences, measurement and dietary influences. Int. J. Food Sci. Nutr. 1996; 47: 233-261.
69. Romero FJ. Antioxidants in peripheral nerve. Free Radic. Biol. Med. 1996; 20: 925-932.
70. Brooks PJ. DNA damage, DNA repair, and alcohol toxicity - a review. Alcohol Clin. Exp. Res. 1997; 21: 1073-1082.
71. Diplock AT. Will the ‘good fairies’ please prove to us that vitamin E lessens human degenerative disease? Free Radic. Res. 1997; 27: 511-532.
72. Chan AC. Vitamin E and atherosclerosis. J. Nutr. 1998; 128: 1593-1596.
73. Supinski G. Free radical induced respiratory muscle dysfunction. Mol. Cell. Biochem. 1998; 179: 99-110.
74. Links M, Lewis C. Chemoprotectants: a review of their clinical pharmacology and therapeutic efficacy. Drugs 1999 57: 293-308.
75. McDonough KH. The role of alcohol in the oxidant antioxidant balance in heart. Front Biosci. 1999; 4: D601-D606.
76. Bender DA. Vitamin E: tocopherols and tocotrienols. In Nutritional biochemistry of the vitamins. Edited by DA Bender, Cambridge: Cambridge University Press, 1992; pp. 87-105.
77. Drevon CA. Absorption, transport and metabolism of vitamin E. Free Radic. Res. Commun. 1991; 14: 229-246.
78. Dutta-Roy AK. Molecular mechanism of cellular uptake and intracellular translocation of alpha-tocopherol: role of tocopherol-binding proteins. Food Chem. Toxicol. 1999; 37: 967-971.
79. Konneh MK, Rutherford C, Anggard E, Ferns GA. Tissue distribution of alpha-tocopherol following dietary supplementation in the rat: effects of concomitant cholesterol feeding. Proc. Soc. Exp. Biol. Med. 1995; 210: 156-161.
80. Shi H, Noguchi N, Niki E. Comparative study on dynamics of antioxidative action of alphatocopheryl hydroquinone, ubiquinol, and alpha-tocopherol against lipid peroxidation. Free Radic. Biol. Med. 1999; 27: 334-346.
81. Reilly ME, Ansell H, Marway JS, Richardson PJ, Peters TJ, Preedy VR. The effect of supplementation on alpha-tocopherol levels in liver, heart and skeletal muscle. Biochem. Soc. Trans. 1995; 23: 466S.
82. Kawase T, Kato S, Lieber CS. Lipid peroxidation and antioxidant defense systems in rat liver after chronic ethanol feeding. Hepatology 1989; 10: 815-821.
83. Seitz HK, Puter PM. Ethanol toxicity and nutritional status. In Nutritional Toxicology. Edited by FN Kotsonis, M Mackay, J Hjella. New York: Raven Press, 2000, pp. 95-116.
84. Meydani M, Seitz HK, Blumberg JB, Russell RM. Effect of chronic ethanol feeding on hepatic and extrahepatic distribution of vitamin E in rats. Alcohol Clin. Exp. Res. 1991; 15: 771-774.
85. Lieber CS. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. N. Engl. J. Med. 1988; 319: 1639-1650.
86. Sadrzadeh SMH, Nanji AA, Price PL, Meydani M. The effect of chronic ethanol feeding on serum and liver alpha and gamma tocopherol levels in normal and vitamin E deficient rats. Gastroenterology 1993; 104: 982A.
87. Tsukamoto H, Kim CM, Horn W, Su L, Brittenham GM. Role of lipid peroxidation in in vivo and in vitro models of liver fibrogenesis. Gastroenterology 1993; 104: 1012A.
88. Kamimura S, Gaal K, Britton RS, Bacon BR, Triadafilopoulos G, Tsukamoto H. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. Hepatology 1992; 16: 448-453.
89. French SW, Wong K, Jui L, Albano E, Hagbjork AL, Ingelman Sundberg M. Effect of ethanol on cytochrome P450 2E1 (CYP2E1), lipid peroxidation, and serum protein adduct formation in relation to liver pathology pathogenesis. Exp. Mol. Pathol. 1993; 58: 61-75.
90. Morimoto M, Hagbjork AL, Nanji AA, Ingelman Sundberg M, Lindros KO, Fu PC, Albano E, French SW. Role of cytochrome P450 2E1 in alcoholic liver disease pathogenesis. Alcohol 1993; 10: 459-464.
91. Gebhardt AC, Lucas D, Menez JF, Seitz HK. Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans. Hepatology 1997; 26: 957-961.
92. Wenzel G, Kulinski B, Ruhlmann C, Ehrhardt D. Alkoholische hepatitis - eine ‘freie radikale’ assoziierte erkrankung. Letalitässenkung durch adjuvante antioxidantientherapie (alcoholic toxic hepatitis - a free radical associated disease. Decreased mortality by adjuvant antioxidant therapy). Z. Gesamte Inn. Med. 1993; 490-496.
93. Whitacre ME, Combs GF Jr, Combs SB, Parker RS. Influence of dietary vitamin E on nutritional pancreatic atrophy in selenium-deficient chicks. J. Nutr. 1987; 117: 460-467.
94. Asayama K, Kooy NW, Burr IM. Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets: decrease of islet manganosuperoxide dismutase. J. Lab. Clin. Med. 1986; 107: 459-464.
95. Douillet C, Chancerelle Y, Cruz C, Maroncles C, Kergonou JF, Renaud S, Ciavatti M. High dosage vitamin E effect on oxidative status and serum lipids distribution in streptozotocin-induced diabetic rats. Biochem. Med. Metab. Biol. 1993; 50: 265-276.
96. Papaccio G, Baccari GC, Frascatore S, Sellitti S, Pisanti FA. The vitamin-E derivative U-83836-E in the low-dose streptozocin-treated mouse: effects on diabetes development. Diabetes Res. Clin. Pract. 1995; 30: 163-171.
97. Koya D, Lee IK, Ishii H, Kanoh H, King GL. Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J. Am. Soc. Nephrol. 1997; 8: 426-435.
98. Douillet C, Bost M, Accominotti M, Borson-Chazot F, Ciavatti M. Effect of selenium and vitamin E supplements on tissue lipids, peroxides, and fatty acid distribution in experimental diabetes. Lipids 1998; 33: 393-399.
99. Vannucchi H, Araujo WF, Bernardes MM, Jordao Junior AA. Effect of different vitamin E levels on lipid peroxidation in streptozotocin-diabetic rats. Int. J. Vitam. Nutr. Res. 1999; 69: 250-254.
100. Sukalski KA, Pinto KA, Berntson JL. Decreased susceptibility of liver mitochondria from diabetic rats to oxidative damage and associated increase in alpha-tocopherol. Free Radic. Biol. Med. 1993; 14: 57-65.
101. Rosen P, Du X, Tschope D. Role of oxygen derived radicals for vascular dysfunction in the diabetic heart: prevention by alpha-tocopherol? Mol. Cell. Biochem. 1998; 188: 103-111.
102. McCarty MF. Complementary measures for promoting insulin sensitivity in skeletal muscle. Med. Hypotheses 1998; 51: 451-464.
103. Jain SK, McVie R, Jaramillo JJ, Palmer M, Smith T, Meachum ZD, Little RL. The effect of modest vitamin E supplementation on lipid peroxidation products and other cardiovascular risk factors in diabetic patients. Lipids 1996; 31:(Suppl.): S87-S90.
104. Caballero B. Vitamin E improves the action of insulin. Nutr. Rev. 1993; 51: 339-340.
105. Mizui T, Doteuchi M. Lipid peroxidation: a possible role in gastric damage induced by ethanol in rats. Life Sci. 1986; 38: 2163-2167.
106. Evangelista S, Meli A. Influence of antioxidants and radical scavengers on ethanol-induced gastric ulcers in the rat. Gen. Pharmacol. 1985; 16: 285-286.
107. Mizui T, Sato H, Hirose F, Doteuchi M. Effect of antiperoxidative drugs on gastric damage induced by ethanol in rats. Life Sci. 1987; 41: 755-763.
108. Albano E, Clot P. Free radicals and ethanol toxicity. In: Alcohol and the gastrointestinal tract. Edited by VR Preedy, RR Watson. Boca Raton, Florida: CRC Press, 1996, pp. 57-68.
109. Seitz HK, Pöschl G, Simanowski UA. Alcohol and cancer: Recent developments in alcoholism. In:The consequences of alcoholism. Edited by M Galanter. New York: Plenum Press, 1998, pp. 67-95.
110. Shimizu M, Lasker JM, Tsutsumi M, Lieber CS. Immunohistochemical localization of ethanolinducible P450 IIE1 in the rat alimentary tract. Gastroenterology 1990; 99: 1044-1053.
111. Hakkak R, Korourian S, Ronis MJ, Ingelman Sundberg M, Badger TM. Effects of diet and ethanol on the expression and localization of cytochromes P450 2E1 and P450 2C7 in the colon of male rats. Biochem. Pharmacol. 1996; 51: 61-69.
112. Baumgarten G, Waldherr RB, Stickel F et al. Enhanced expression of cytochrome P450 2E1 in the oropharyngeal mucosa in alcoholics with cancer. Annual Meeting International Society of Biomedical Research on Alcoholism, Washington DC, June 22-27, (abstract), 1996.
113. Gossrau R, Frederiks WM, van Noorden CJ. Histochemistry of reactive oxygen-species (ROS)- generating oxidases in cutaneous and mucous epithelia of laboratory rodents with special reference to xanthine oxidase. Histochemistry 1990; 94: 539-544.
114. Eskelson CD, Odeleye OE, Watson RR, Earnest DL, Mufti SI. Modulation of cancer growth by vitamin E and alcohol. Alcohol Alcohol. 1993; 28: 117-125.
115. Vincon P, Wunderer J, Simanowski UA, Preedy VR, Peters TJ, Waldherr R, Seitz HK. Inhibition of alcohol-associated hyperregeneration in the rat colon by alpha-tocopherol. Alcohol Clin. Exp. Res. 2000; 24(Suppl.): 213A.
116. Holvoet P, Collen D. Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis. Atherosclerosis 1998; 137(Suppl.): S33-S38.
117. Suzukawa M, Ayaori M, Shige H, Hisada T, Ishikawa T, Nakamura H. Effect of supplementation with vitamin E on LDL oxidizability and prevention of atherosclerosis. Biofactors 1998; 7: 51-54.
118. Stocker R. The ambivalence of vitamin E in atherogenesis. Trends Biochem. Sci. 1999; 24: 219-223.
119. Enstrom JE, Pauling L. Mortality among health-conscious elderly Californians. Proc. Natl. Acad. Sci. USA 1982; 79: 6023-6027.
120. Ihara Y, Nobukuni K, Namba R, Kamisaka K, Kibata M, Kajinami K, Fujita H, Mabuchi H, Shirabe T, Ohshima K et al. A family of familial hypercholesterolemia with cerebral infarction and without coronary heart disease. An unusual case with corneal opacity, polyneuropathy and carpal tunnel syndrome in the family: therapy with probucol and tocopherol nicotinate. J. Neurol. Sci. 1991; 106: 10-18.
121. Bowry VW, Ingold KU, Stocker R. Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem. J. 1992; 288: 341-344.
122. Bachem MG, Wendelin D, Schneiderhan W, Haug C, Zorn U, Gross HJ, Schmid-Kotsas A, Grunert A. Depending on their concentration oxidized low density lipoproteins stimulate extracellular matrix synthesis or induce apoptosis in human coronary artery smooth muscle cells. Clin. Chem. Lab. Med. 1999; 37: 319-326.
123. Devaraj S, Li D, Jialal I. The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. J. Clin. Invest. 1996; 98: 756-763.
124. Cachia O, Leger CL, Descomps B. Monocyte superoxide production is inversely related to normal content of alpha-tocopherol in low-density lipoprotein. Atherosclerosis 1998; 138: 263-269.
125. Mabile L, Fitoussi G, Periquet B, Schmitt A, Salvayre R, Negre-Salvayre A. Alpha-tocopherol and trolox block the early intracellular events (TBARS and calcium rises) elicited by oxidized low density lipoproteins in cultured endothelial cells. Free Radic. Biol. Med. 1995; 19: 177-187.
126. Wen Y, Killalea S, McGettigan P, Feely J. Lipid peroxidation and antioxidant vitamins C and E in hypertensive patients. Ir. J. Med. Sci. 1996; 165: 210-212.
127. Aejmelaeus RT, Holm P, Kaukinen U, Metsa-Ketela TJ, Laippala P, Hervonen AL, Alho HE. Age-related changes in the peroxyl radical scavenging capacity of human plasma. Free Radic. Biol. Med. 1997; 23: 69-75.
128. Slattery ML, Jacobs DR Jr, Dyer A, Benson J, Hilner JE, Caan BJ. Dietary antioxidants and plasma lipids: the Cardia Study. J. Am. Coll. Nutr. 1995; 14: 635-642.
129. Iuliano L, Pedersen JZ, Camastra C, Bello V, Ceccarelli S, Violi F. Protection of low density lipoprotein oxidation by the antioxidant agent IRFI005, a new synthetic hydrophilic vitamin E analogue. Free Radic. Biol. Med. 1999; 26: 858-868.
130. Martin-Nizard F, Boullier A, Fruchart JC, Duriez P. Alpha-tocopherol but not beta-tocopherol inhibits thrombin-induced PKC activation and endothelin secretion in endothelial cells. J. Cardiovasc. Risk 1998; 5: 339-345.
131. Mak IT, Murphy A, Hopper A, Witiak D, Ziemniak J, Weglicki WB. Potent inhibitory activities of hydrophobic aci-reductones (2-hydroxytetronic acid analogs) against membrane and human low-density lipoprotein oxidation. Biochem. Pharmacol. 1998; 55: 1921-1926.
132. Kontush A, Spranger T, Reich A, Baum K, Beisiegel U. Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of alpha-carotene and gamma-tocopherol. Atherosclerosis 1999; 144: 117-122.
133. Torun M, Avci N, Yardim S. Serum levels of vitamin E in relation to cardiovascular diseases. J. Clin. Pharm. Ther. 1995; 20: 335-340.
134. Kim SY, Lee-Kim YC, Kim MK, Suh JY, Chung EJ, Cho SY, Cho BK, Suh I. Serum levels of antioxidant vitamins in relation to coronary artery disease: a case control study of Koreans. Biomed. Environ. Sci. 1996; 9: 229-235.
135. Klipstein-Grobusch K, Geleijnse JM, den Breeijen JH, Boeing H, Hofman A, Grobbee DE, Witteman JC. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. Am. J. Clin. Nutr. 1999; 69: 261-266.
136. Kostner K, Hornykewycz S, Yang P, Neunteufl T, Glogar D, Weidinger F, Maurer G, Huber K. Is oxidative stress causally linked to unstable angina pectoris? A study in 100 CAD patients and matched controls. Cardiovasc. Res. 1997; 36: 330-336.
137. Hu FB, Stampfer MJ, Manson JE, Rimm EB, Colditz GA, Rosner BA, Speizer FE, Hennekens CH, Willett WC. Frequent nut consumption and risk of coronary heart disease in women:prospective cohort study. BMJ 1998; 317: 1341-1345.
138. Liu S, Stampfer MJ, Hu FB, Giovannucci E, Rimm E, Manson JE, Hennekens CH, Willett WC. Whole-grain consumption and risk of coronary heart disease: results from the Nurses’ Health Study. Am. J. Clin. Nutr. 1999; 70: 412-419.
139. Rozewicka L, Barcew-Wiszniewska B, Wojcicki J, Samochowiec L, Krasowska B. Protective effect of selenium and vitamin E against changes induced in heart vessels of rabbits fed chronically on a high-fat diet. Kitasato. Arch. Exp. Med. 1991; 64: 183-192.
140. Ruf JC. Wine and polyphenols related to platelet aggregation and atherothrombosis. Drugs Exp. Clin. Res. 1999; 25: 125-131.
141. Abu Amsha R, Croft KD, Puddey IB, Proudfoot JM, Beilin LJ. Phenolic content of various beverages determines the extent of inhibition of human serum and low-density lipoprotein oxidation in vitro: identification and mechanism of action of some cinnamic acid derivatives from red wine. Clin. Sci. Colch. 1996; 91: 449-458.
142. Soleas GJ, Diamandis EP, Goldberg DM. Wine as a biological fluid: history, production, and role in disease prevention. J. Clin. Lab. Anal. 1997; 11: 287-313.
143. Constant J. Alcohol, ischemic heart disease, and the French paradox. Coron. Artery. Dis. 1997; 8: 645-649.
144. Serafini M, Maiani G, Ferro-Luzzi A. Alcohol-free red wine enhances plasma antioxidant capacity in humans. J. Nutr. 1998; 128: 1003-1007.
145. Paganga G, Miller N, Rice-Evans CA. The polyphenolic content of fruit and vegetables and their antioxidant activities. What does a serving constitute? Free Radic. Res. 1999; 30: 153-162.
146. de Rijke YB, Demacker PN, Assen NA, Sloots LM, Katan MB, Stalenhoef AF. Red wine consumption does not affect oxidizability of low-density lipoproteins in volunteers. Am. J. Clin. Nutr. 1996; 63: 329-334.
147. Borghi C, Ambrosioni E. Primary and secondary prevention of myocardial infarction. Clin. Exp. Hypertens. 1996; 18: 547-558.
148. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-786.
149. Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am. J. Clin. Nutr. 1996; 64: 190-196.
150. Anonymous. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: the results of the GISSI-Prevention Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 1999; 354: 447-455.
151. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ, Willett WC. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA 1996; 275: 447-451.
152. Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE, Hennekens C, Stampfer MJ. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998; 279: 359-364.
153. Phonpanichrasamee C, Komaratat P, Wilairat P. Hypocholesterolemic effect of vitamin E on cholesterol-fed rabbit. Int. J. Vitam. Nutr. Res. 1990; 60: 240-244.
154. Wojcicki J, Rozewicka L, Barcew Wiszniewska B, Samochowiec L, Juzwiak S, Kadlubowska D, Tustanowski S, Juzyszyn Z. Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis 1991; 87: 9-16.
155. Sirikci O, Ozer NK, Azzi A. Dietary cholesterol-induced changes of protein kinase C and the effect of vitamin E in rabbit aortic smooth muscle cells. Atherosclerosis 1996; 126: 253-263.
156. Jain SK, Levine SN. Elevated lipid peroxidation and vitamin E-quinone levels in heart ventricles of streptozotocin-treated diabetic rats. Free Radic. Biol. Med. 1995; 18: 337-341.
157. Ascherio A, Rimm EB, Hernan MA, Giovannucci E, Kawachi I, Stampfer MJ, Willett WC. Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann. Intern. Med. 1999; 130: 963-970.
158. Friedman HS. Cardiovascular effects of alcohol. Recent Dev. Alcohol 1998; 14: 135-166.
159. Freedman JE, Farhat JH, Loscalzo J, Keaney JF Jr. Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 1996; 94: 2434-2440.
160. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93: 841-842.
161. Preedy VR, Richardson PJ. Alcoholic cardiomyopathy: clinical and experimental pathological changes. Herz. 1996; 21: 241-247.
162. Preedy VR, Richardson PJ. Alcohol and the heart. In: Current issues in cardiovascular therapy. Edited by HL Elliott. London: Martin Dunitz, 1997, pp. 83-95.
163. Richardson PJ, Patel VB, Preedy VR. Alcohol and the myocardium. Novartis Found Symp. 1998; 216: 35-45.
164. Simon JA, Hudes ES. Serum ascorbic acid and cardiovascular disease prevalence in U.S. adults:the Third National Health and Nutrition Examination Survey (NHANES III). Ann. Epidemiol. 1999; 9: 358-365.
165. Simonetti P, Brusamolino A, Pellegrini N, Viani P, Clemente G, Roggi C, Cestaro B. Evaluation of the effect of alcohol consumption on erythrocyte lipids and vitamins in a healthy population. Alcohol Clin. Exp. Res. 1995; 19: 517-522.
166. Ward RJ, Peters TJ. The antioxidant status of patients with either alcohol-induced liver damage or myopathy. Alcohol Alcohol. 1992; 27: 359-365.
167. Simonetti P, Cestaro B, Porrini M, Viani P, Roggi C, Testolin G. Effect of alcohol intake on lipids and fat-soluble vitamins in blood. Minerva Med. 1993; 84: 447-452.
168. Hibbs RG, Ferrans VJ, Black WC, Weilbaecher DG, Walsh JJ, Burch GE. Alcoholic cardiomyopathy. An electron microscopy study. Am. Heart J. 1965; 69: 766-769.
169. Garcia Bunuel L. Lipid peroxidation in alcoholic myopathy and cardiomyopathy. Med. Hypotheses 1984; 13: 217-231.
170. Tsiplenkova VG, Vikhert AM, Cherpachenko NM. Ultrastructural and histochemical observations in human and experimental alcoholic cardiomyopathy. J. Am. Coll. Cardiol. 1986; 8: 22A-32A.
171. Jaatinen P, Saukko P, Hervonen A. Chronic ethanol exposure increases lipopigment accumulation in human heart. Alcohol Alcohol. 1993; 28: 559-569.
172. Antonenkov VD, Pirozhkov SV, Popova SV, Panchenko LF. Effect of chronic ethanol, catalase inhibitor 3-amino-1,2,4-triazole and clofibrate treatment on lipid peroxidation in rat myocardium. Int. J. Biochem. 1989; 21: 1313-1318.
173. Edes I, Toszegi A, Csanady M, Bozoky B. Myocardial lipid peroxidation in rats after chronic alcohol ingestion and the effects of different antioxidants. Cardiovasc. Res. 1986; 20: 542-548.
174. Nordmann R, Ribiere C, Rouach H. Involvement of oxygen free radicals in the metabolism and toxicity of ethanol. Prog. Clin. Biol. Res. 1987; 241: 201-213.
175. Coudray C, Boucher F, Richard MJ, Arnaud J, De Leiris J, Favier A. Zinc deficiency, ethanol, and myocardial ischemia affect lipoperoxidation in rats. Biol. Trace Elem. Res. 1991; 30: 103-118.
176. Pirozhkov SV, Eskelson CD, Watson RR, Hunter GC, Piotrowski JJ, Bernhard V. Effect of chronic consumption of ethanol and vitamin E on fatty acid composition and lipid peroxidation in rat heart tissue. Alcohol 1992; 9: 329-334.
177. Ribiere C, Hininger I, Rouach H, Nordmann R. Effects of chronic ethanol administration on free radical defence in rat myocardium. Biochem. Pharmacol. 1992; 44: 1495-1500.
178. Choy PC, O K, Man RY, Chan AC. Phosphatidylcholine metabolism in isolated rat heart:modulation by ethanol and vitamin E. Biochim. Biophys. Acta 1989; 1005: 225-232.
179. Matias WG, Traore A, Bonini M, Sanni A, Creppy EE. Oxygen reactive radicals production in cell culture by okadaic acid and their implication in protein synthesis inhibition. Hum. Exp. Toxicol. 1999; 18: 634-639.
180. Uto A, Dux E, Kusumoto M, Hossmann KA. Delayed neuronal death after brief histotoxic hypoxia in vitro. J. Neurochem. 1995; 64: 2185-2192.
181. Fraga CG, Zamora R, Tappel AL. Damage to protein synthesis concurrent with lipid peroxidation in rat liver slices: effect of halogenated compounds, peroxides, and vitamin E1. Arch. Biochem. Biophys. 1989; 270: 84-91.
182. Zloch Z. Temporal changes of the lipid peroxidation in rats after acute intoxication by ethanol. Z. Naturforsch. C. 1994; 49: 359-362.
183. Lecomte E, Herbeth B, Pirollet P, Chancerelle Y, Arnaud J, Musse N, Paille F, Siest G, Artur Y. Effect of alcohol consumption on blood antioxidant nutrients and oxidative stress indicators. Am. J. Clin. Nutr. 1994; 60: 255-261.
184. Kurose I, Higuchi H, Miura S, Saito H, Watanabe N, Hokari R, Hirokawa M, Takaishi M, Zeki S, Nakamura T, Ebinuma H, Kato S, Ishii H. Oxidative stress-mediated apoptosis of hepatocytes exposed to acute ethanol intoxication. Hepatology 1997; 25: 368-378.
185. Reinke LA, Moore DR, McCay PB. Free radical formation in livers of rats treated acutely and chronically with alcohol. Alcohol Clin. Exp. Res. 1997; 21: 642-646.
186. Reinke LA, McCay PB. Spin trapping studies of alcohol-initiated radicals in rat liver: influence of dietary fat. J. Nutr. 1997; 127: 899S-902S.
187. Redetzki JE, Griswold KE, Nopajaroonsri C, Redetzki HM. Amelioration of cardiotoxic effects of alcohol by vitamin E. J. Toxicol. Clin. Toxicol. 1983; 20: 319-331.
188. Peuchant E, Carbonneau MA, Dubourg L, Thomas MJ, Perromat A, Vallot C, Clerc M. Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: vitamins A, E, and iron status. Free Radic. Biol. Med. 1994; 16: 339-346.
189. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin. Chem. 1995; 41: 1135-1138.
190. Mune M, Yukawa S, Kishino M, Otani H, Kimura K, Nishikawa O, Takahashi T, Kodama N, Saika Y, Yamada Y. Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients. Kidney Int. Suppl. 1999; 71: S126-S129.
191. Galli F, Canestrari F, Buoncristiani U. Biological effects of oxidant stress in haemodialysis: the possible roles of vitamin E. Blood Purif. 1999; 17: 79-94.
192. Westermarck T. Selenium content of tissues in Finnish infants and adults with various diseases, and studies on the effects of selenium supplementation in neuronal ceroid lipofuscinosis patients. Acta Pharmacol. Toxicol. Copenh. 1977; 41: 121-128.
193. Werlin SL, Harb JM, Swick H, Blank E. Neuromuscular dysfunction and ultrastructural pathology in children with chronic cholestasis and vitamin E deficiency. Ann. Neurol. 1983; 13: 291-296.
194. Sokol RJ, Heubi JE, McGraw C, Balistreri WF. Correction of vitamin E deficiency in children with chronic cholestasis. II. Effect on gastrointestinal and hepatic function. Hepatology 1986; 6: 1263-1269.
195. Stewart SM, Uauy R, Waller DA, Kennard BD, Andrews WS. Mental and motor development correlates in patients with end-stage biliary atresia awaiting liver transplantation. Pediatrics 1987; 79: 882-888.
196. Perlmutter DH, Gross P, Jones HR, Fulton A, Grand RJ. Intramuscular vitamin E repletion in children with chronic cholestasis. Am. J. Dis. Child. 1987; 141: 170-174.
197. Sokol RJ. Vitamin E deficiency and neurologic disease. Annu. Rev. Nutr. 1988; 8: 351-373.
198. Kaufman SS, Murray ND, Wood RP, Shaw BW Jr, Vanderhoof JA. Nutritional support for the infant with extrahepatic biliary atresia. J. Pediatr. 1987; 110: 679-686.
199. Tazawa Y, Nakagawa M, Yamada M, Konno T, Tada K, Ohi R, Kasai M. Serum vitamin E levels in children with corrected biliary atresia. Am. J. Clin. Nutr. 1984; 40: 246-250.
200. Neu J, Valentine C, Meetze W. Scientifically-based strategies for nutrition of the high-risk low birth weight infant. Eur. J. Pediatr. 1990; 150: 2-13.
201. Cywes C, Millar AJ. Assessment of the nutritional status of infants and children with biliary atresia. S. Afr. Med. J. 1990; 77: 131-135.
202. Boudreaux JP, Hayes DH, Mizrahi S, Maggiore P, Blazek J, Dick D. Use of water-soluble liquid vitamin E to enhance cyclosporine absorption in children after liver transplant. Transplant Proc. 1993; 25: 1875.
203. Sokol RJ, Butler Simon N, Conner C, Heubi JE, Sinatra FR, Suchy FJ, Heyman MB, Perrault J, Rothbaum RJ, Levy J et al. Multicenter trial of d-alpha-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis. Gastroenterology 1993; 104: 1727-1735.
204. Lorch V, Murphy D, Hoersten LR, Harris E, Fitzgerald J, Sinha SN. Unusual syndrome among premature infants: association with a new intravenous vitamin E product. Pediatrics 1985; 75: 598-602.
205. Siman CM, Eriksson UJ. Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes 1997; 46: 1054-1061.
206. Suarez A, Ramirez-Tortosa M, Gil A, Faus MJ. Addition of vitamin E to long-chain polyunsaturated fatty acid-enriched diets protects neonatal tissue lipids against peroxidation in rats. Eur. J. Nutr. 1999; 38: 169-176.
207. Surai PF, Noble RC, Speake BK. Relationship between vitamin E content and susceptibility to lipid peroxidation in tissues of the newly hatched chick. Br. Poult. Sci. 1999; 40: 406-410.
208. Van Vleet JF, Ferrans VJ. Ultrastructural changes in skeletal muscle of selenium-vitamin E-deficient chicks. Am. J. Vet. Res. 1976; 37: 1081-1089.
209. Van Vleet J, Ferrans VJ. Ultrastructural alterations in skeletal muscle of ducklings fed seleniumvitamin E-deficient diet. Am. J. Vet. Res. 1977; 38: 1399-1405.
210. Dahlin KJ, Chan AC, Benson ES, Hegarty PV. Rehabilitating effect of vitamin E therapy on the ultrastructural changes in skeletal muscles of vitamin E-deficient rabbits. Am. J. Clin. Nutr. 1978; 31: 94-99.
211. Van Vleet JF, Ruth G, Ferrans VJ. Ultrastructural alterations in skeletal muscle of pigs with seleniumvitamin E deficiency. Am. J. Vet. Res. 1976; 37: 911-922.
212. Niyo Y, Glock RD, Ramsey FK, Ewan RC. Effects of intramuscular injections of selenium and vitamin E on selenium-vitamin E deficiency in young pigs. Am. J. Vet. Res. 1977; 38: 1479-1484.
213. Preedy VR, Reilly M, Mantle D, Peters TJ. Free radicals and antioxidants in the pathogenesis of alcoholic myopathy. In: Free radicals and skeletal muscle. Edited by AE Reznick, DL Packer, CK Sen, JO Holloszy, MJ Jackson. Basel: Birkhauser Verlag, 1998, pp. 283-293.
214. Preedy VR, Reilly ME, Peters TJ. A current and retrospective analysis of whether the animal model of alcoholic myopathy is suitable for studying its clinical counterpart. Addict. Biol. 1999; 4: 241-242.
215. Preedy VR, Reilly ME, Patel VB, Richardson PJ, Peters TJ. Protein metabolism in alcoholism:effects on specific tissues and the whole body. Nutrition 1999; 15: 604-608.
216. Fernandez Sola J, Villegas E, Nicolas JM, Deulofeu R, Antunez E, Sacanella E, Estruch R, Urbano Marquez A. Serum and muscle levels of alpha-tocopherol, ascorbic acid, and retinol are normal in chronic alcoholic myopathy. Alcohol Clin. Exp. Res. 1998; 22: 422-427.
217. Wilson TM, Morrison HA, Palmer NC, Finley GG, van Dreumel AA. Myodegeneration and suspected selenium/vitamin E deficiency in horses. J. Am. Vet. Med. Assoc. 1976; 169: 213-217.
218. Whanger PD, Weswig PH, Schmitz JA, Oldfield JE. Effects of selenium and vitamin E on blood selenium levels, tissue glutathione peroxidase activities and white muscle disease in sheep fed purified or hay diets. J. Nutr. 1977; 107: 1298-1307.
219. Turner RJ, Wheatley LE, Beck NF. Impaired mitogen responses in lambs with white muscle disease. Res. Vet. Sci. 1984; 37: 357-358.
220. Higuchi T, Ichijo S, Osame S, Ohishi H. Studies on serum selenium and tocopherol in white muscle disease of foal. Nippon Juigaku Zasshi 1989; 51: 52-59.
221. Hoshino Y, Ichijo S, Osame S, Takahashi E. Studies on serum tocopherol, selenium levels and blood glutathione peroxidase activities in calves with white muscle disease. Nippon Juigaku Zasshi 1989; 51: 741-748.
222. Osame S, Ohtani T, Ichijo S. Studies on serum tocopherol and selenium levels and blood glutathione peroxidase activities in lambs with white muscle disease. Nippon Juigaku Zasshi 1990; 52: 705-710.
223. de Gritz BG, Rahko T, Korpela H. Diet-induced lipofuscin and ceroid formation in growing pigs. J. Comp. Pathol. 1994; 110: 11-24.
224. de Gritz BG. Copper-zinc superoxide dismutase (CuZnSOD) in antioxidant deficient pigs. Zentralbl Veterinarmed A 1995; 42: 561-573.
225. Dickerson B, McKnight A, Middleton J, Tyler JW, Bagley R, Valdez R. Electromyographic evaluation of a calf with white muscle disease. Vet. Rec. 1997; 140: 431-432.
226. Lofstedt J. White muscle disease of foals. Vet. Clin. North Am. Equine Pract. 1997; 13: 169-185.
227. Walsh DM, Kennedy DG, Goodall EA, Kennedy S. Antioxidant enzyme activity in the muscles of calves depleted of vitamin E or selenium or both. Br. J. Nutr. 1993; 70: 621-630.
228. Halliwell B, Aeschbach R, Loliger J, Aruoma OI. The characterization of antioxidants. Food Chem. Toxicol. 1995; 33: 601-617.